A Phase III Randomized Trial of the Reduction of Chemotherapy in Philadelphia Chromosome-positive ALL of Young Adults

NCT02611492 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

265

Enrollment

OTHER

Sponsor class

Conditions

Philadelphia Chromosome Positive Adult Acute Lymphoblastic Leukemia

Interventions

DRUG: Nilotinib
DRUG: Methotrexate
DRUG: Aracytine (Ara C)
DRUG: Granulocyte Colony-Stimulating Factor (G-CSF)
DRUG: Depomedrol
DRUG: Dexamethasone
DRUG: Vincristine
DRUG: Imatinib
DRUG: 6 Mercaptopurine (6MP)

Sponsor

Assistance Publique - Hôpitaux de Paris